RVX Chart by TradingView

Business Description

Resverlogix is a biotechnology company focused on the two largest drug markets – cancer and cholesterol. Its unique technology is focused on increasing HDL’s (good cholesterol) as opposed to the more common focus of lowering LDL’s (bad cholesterol).

Website: http://www.resverlogix.com/


Resverlogix to Present at Upcoming Conferences Oct. 13, 2021
Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial Oct. 12, 2021
Resverlogix Announces Management Change Jul. 6, 2021
How Much Of Resverlogix Corp. (TSE:RVX) Do Institutions Own? Jul. 2, 2021
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer Jun. 24, 2021